Workup and Staging of Malignant Melanoma

Surgical Clinics of North America

Volumn 94, Issue 5, 2014, Pages 963-972

  Kauffmann, Rondi M ^a   Chen, Steven L ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Melanoma; Melanoma staging; Melanoma workup; Skin neoplasms

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

CANCER PROGNOSIS; CANCER STAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; ECHOGRAPHY; HUMAN; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; MEDICAL HISTORY; MELANOMA; METASTATIC MELANOMA; PHYSICAL EXAMINATION; PREOPERATIVE EVALUATION; PUNCH BIOPSY; REVIEW; SENTINEL LYMPH NODE BIOPSY; SKIN BIOPSY; THORAX RADIOGRAPHY; TUMOR INVASION; TUMOR VOLUME; DIAGNOSTIC IMAGING; MELANOMA STAGING; MELANOMA WORKUP; METHODOLOGY; PATHOLOGY; SKIN TUMOR;

MELANOMA; MELANOMA STAGING; MELANOMA WORKUP; SKIN NEOPLASMS;

DIAGNOSTIC IMAGING; HUMANS; MELANOMA; NEOPLASM INVASIVENESS; NEOPLASM STAGING; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 84907676881     PISSN: 00396109     EISSN: 15583171     Source Type: Journal    
DOI: 10.1016/j.suc.2014.07.001     Document Type: Review

References (49)

1. American Cancer Society. "What are the key statistics about melanoma?". Available at: . Accessed March 15, 2014. http://www.cancer.org/cancer/skincancer-melanoma/detailedguide/melanoma-skin-cancer-key-statistics.
2. SEER Stat Fact Sheet: Melanoma. From the National Cancer Institute's Surveillance, Epidemiology, and End Results Database. Available at: . Accessed March 15, 2014. http://seer.cancer.gov/statfacts/html/melan.html.
3. Casara D., Rubello D., Rossi C.R., et al. Sentinel node biopsy in cutaneous melanoma patients: technical and clinical aspects. Tumori 2000, 86(4):339-340.
4. Cameron J.L. Current surgical therapy 2011, Elsevier, Philadelphia.
5. Melanoma. Available at: . Accessed March 15, 2014. http://en.wikipedia.org/wiki/Melanoma.
6. James W.D., Berger T.G., Elston D.M. Andrews' diseases of the skin: clinical dermatology 2006, Saunders Elsevier, Philadelphia.
7. Rapini R.P., Bolognia J.L., Jorizzo J.L. Dermatology: 2-volumme set 2007, Mosby, St Louis (MO).
8. Leffell D.J. Total skin: the definitive guide to total skin care for life 2000, Yale School of Medicine, New Haven (CT).
9. Skin- Melanocytic tumor. Available at: . Accessed March 24, 2014. http://www.pathologyoutlines.com.
10. Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 1970, 172(5):902-908.
11. Weedon D. Skin pathology 2002, Churchill-Livingstone, Sydney (Australia).
12. Reed D., Kudchadkar R., Zager J.S., et al. Controversies in the evaluation and management of atypical melanocytic proliferations in children, adolescents, and young adults. JNatl Compr Canc Netw 2013, 11(6):679-686.
13. Bichakjian C.K., Halpern A.C., Johnson T.M., et al. Guidelines of care for the management of primary cutaneous melanoma. American Academy of Dermatology. JAm Acad Dermatol 2011, 65(5):1032-1047.
14. Mathew R., Messina J.L. Recent advances in pathologic evaluation and reporting of melanoma. Semin Oncol 2012, 39(2):184-191.
15. Sondak V.K., Taylor J.M., Sabel M.S., et al. Mitotic rate and younger age are predictors of sentinel lymph node positivity: lessons learned from a generation of a probabilistic model. Ann Surg Oncol 2004, 11(3):247-258.
16. Gouley A. Melanoma staging. Mitotic rate now recognized as the most powerful predictor. Adv NPs PAs 2013, 4(5):31-32.
17. Hale C.S., Qian M., Ma M.W., et al. Mitotic rate in melanoma: prognostic value of immunostaining and computer-assisted image analysis. Am J Surg Pathol 2013, 37(6):882-889.
18. Gerami P., Busam K.J. Cytogenetic and mutational analyses of melanocytic tumors. Dermatol Clin 2012, 30(4):555-566.
19. Morton D.L., Thompson J.F., Cochran A.J., et al. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. NEngl J Med 2014, 370(7):599-609.
20. Ross M.I., Gershenwald J.E. Sentinel lymph node biopsy for melanoma: a critical update for dermatologists after two decades of experience. Clin Dermatol 2013, 31(3):298-310.
21. Lotti T., Bruscino N., Hercogova J., et al. Controversial issues on melanoma. Dermatol Ther 2012, 25(5):458-462.
22. Morton D.L., Wen D.R., Wong J.H., et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992, 127:392-399.
23. Morton D.L., Thompson J.F., Cochran A.J., et al. Sentinel node biopsy or nodal observation in melanoma. NEngl J Med 2006, 355:1307-1317.
24. Johnson T.M., Bradford C.R., Gruber S.B., et al. Staging workup, sentinel node biopsy, and follow-up tests for melanoma: update of current concepts. Arch Dermatol 2004, 140(1):107-113.
25. Dzwierzynski W.W. Managing malignant melanoma. Plast Reconstr Surg 2013, 132(3):446e-460e.
26. Han D., Yu D., Zhao X., et al. Sentinel node biopsy is indicated for thin melanomas> 0.76 mm. Ann Surg Oncol 2012, 19(11):3335-3342.
27. van Akkooi A.C., Nowecki Z.I., Voit C., et al. Sentinel node tumor burden according to the Rotterdam criteria is the most important prognostic factor for survival in melanoma patients: a multicenter study in 388 patients with positive sentinel nodes. Ann Surg 2008, 248(6):949-955.
28. Leung A.M., Morton D.L., Ozao-Choy J., et al. Staging of regional lymph nodes in melanoma: a case for including non-sentinel lymph node positivity in the American Joint Committee on Cancer staging system. JAMA Surg 2013, 148(9):879-884.
29. Bilimoria K.Y., Balch C.M., Bentrem D.J., et al. Complete lymph node dissection for sentinel node positive melanoma. Ann Surg Oncol 2010, 15(6):1566-1576.
30. Multicenter selective lymphadenectomy trial II (MSLT-II). Available at: . Accessed March 31, 2014. http://clinicaltrials.gov/show/NCT00297895.
31. Blaheta H.J., Sotlar K., Breuninger H., et al. Does intensive histopathological workup by serial sectioning increase the detection of lymph node micrometastasis in patients with primary cutaneous melanoma?. Melanoma Res 2001, 11(1):57-63.
32. Dalton S.R., Gerami P., Kolaitis N.A., et al. Use of fluorescence in situ hybridization (FISH) to distinguish intranodal nevus from metastatic melanoma. Am J Surg Pathol 2010, 34(2):231-237.
33. Vermeeren L., van der Ent F.W., Hulsewe K.W. Is there an indication for routine chest x-ray in initial staging of melanoma?. JSurg Res 2011, 166(1):114-119.
34. Terhune M.H., Swanson N., Johnson T.M. Use of chest radiography in the initial evaluation of patients with localized melanoma. Arch Dermatol 1998, 134(5):569-572.
35. De Giorgi V., Gori A., Grazzini M., et al. Contrast-enhanced ultrasound: a filter role in AJCC stage I/II melanoma patients. Oncology 2010, 79(5-6):370-375.
36. van Rijk M.C., Teertstra H.J., Peterse J.L., et al. Ultrasonography and fine-needle aspiration cytology in the preoperative evaluation of melanoma patients eligible for sentinel node biopsy. Ann Surg Oncol 2006, 13(11):1511-1516.
37. Marone U., Catalano O., Caraco C., et al. Can high-resolution ultrasound avoid the sentinel lymph-node biopsy procedure in the staging process of patients with stage I-II cutaneous melanoma?. Ultraschall Med 2012, 33(7):E179-E185.
38. Pandalai P.K., Dominguez F.J., Michaelson J., et al. Clinical value of radiographic staging in patients diagnosed with AJCC stage III melanoma. Ann Surg Oncol 2011, 18(2):506-513.
39. Prakoso E., Selby W.S. Capsule endoscopy in patients with malignant melanoma. Am J Gastroenterol 2007, 102(6):1204-1208.
40. Khansur T., Sanders J., Das S.K. Evaluation of staging workup in malignant melanoma. Arch Surg 1989, 124(7):847-849.
41. Orfaniotis G., Mennie J.C., Fairbairn N., et al. Findings of computed tomography in stage IIB and IIC melanoma: a six-year retrospective study in the south-east of Scotland. JPlast Reconstr Aesthet Surg 2012, 65(9):1216-1219.
42. Niebling M.G., Bastiaannet E., Hoekstra O.S., et al. Outcome of clinical stage III melanoma patients with FDG-PET and whole-body CT added to the diagnostic workup. Ann Surg Oncol 2013, 20(9):3098-3105.
43. Bourgeois A.C., Chang T.T., Fish L.M., et al. Positron emission tomography/computed tomography in melanoma. Radiol Clin North Am 2013, 51(5):865-879.
44. Francis I.R., Brown R.K., Avram A.M. The clinical role of CT/PET in oncology: an update. Cancer Imaging 2005, 5:S68-S75.
45. Wevers K.P., Kruijiff S., Speijers M.J., et al. S-100B is a stronger prognostic biomarker than LDH in stage IIIB-C melanoma. Ann Surg Oncol 2013, 20(8):2772-2779.
46. Moreau S., Saiag P., Aegerter P., et al. Prognostic value of BRAF-V600 mutations in melanoma patients after resection of metastatic lymph nodes. Ann Surg Oncol 2012, 19(13):4314-4321.
47. Ollila D.W., Essner R., Wanek L.A., et al. Surgical resection for melanoma metastatic to the gastrointestinal tract. Arch Surg 1996, 131:975-980.
48. Piris A., Lobo A.C., Duncan L.M. Melanoma staging: where are we now?. Dermatol Clin 2012, 30(4):581-592.
49. Edge S., Byrd D.R., Compton C.C., et al. AJCC cancer staging manual 2010, Springer, Chicago. 7th edition.